`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX INC.
`Petitioner,
`v.
`UCB BIOPHARMA SPRL
`Patent Owner.
`U.S. Patent No. 8,633,194 to Fanara et al.
`Issue Date: January 21, 2014
`Title: Pharmaceutical Composition of Piperazine Derivatives
`Inter Partes Review No.: IPR2019-00400
`
`PETITIONER’S OBJECTIONS TO PATENT OWNER’S
`DEMONSTRATIVE EXHIBITS
`
`
`
`Pursuant to Paper 41, Petitioner hereby files the following objection(s) to
`
`Patent Owner’s demonstrative exhibits:
`
` Demonstrative Exhibit Slide 12 in its entirety. Basis for the
`
`objection: This is new argument/evidence not presented or
`
`advanced in any of the papers or record evidence.
`
`A copy of Demonstrative Exhibit Slide 12 is attached thereto.
`
`Date: April 17, 2020
`
`RESPECTFULLY SUBMITTED,
`Katten Muchin Rosenman LLP
`/Jitendra Malik /
`Jitendra Malik (Reg. No. 55,823)
`
`Lead Counsel for Petitioner
`Apotex, Inc.
`
`1
`
`
`
`
`
`CERTIFICATION OF SERVICE ON PATENT OWNER
`Pursuant to 37 C.F.R. §§ 42.6(e), 42.8(b)(4), and 42.105, the undersigned
`
`certifies that on April 17th, 2020, a complete copy of the foregoing Paper was served
`
`via email to the Patent Owner by serving the correspondence address of record for
`
`the ’194 patent:
`
`James S. Trainor, Jr.
`Robert E. Counihan
`FENWICK & WEST LLP
`1211 Avenue of the Americas, 32nd Floor
`New York, NY 10036
`
`Erica R. Sutter
`FENWICK & WEST LLP
`801 California Street
`Mountain View, CA 94041
`
`Respectfully submitted,
`Katten Muchin Rosenman LLP
`By: /Jitendra Malik/
`
`3
`
`